{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:11:47Z","timestamp":1759529507579},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1992]]},"DOI":"10.1007\/bf00684844","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T08:41:26Z","timestamp":1101717686000},"page":"439-444","source":"Crossref","is-referenced-by-count":24,"title":["Comparison of the blood-brain barrier and liver penetration of acridine antitumor drugs"],"prefix":"10.1007","volume":"29","author":[{"given":"Eain M.","family":"Cornford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Paxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"967","volume":"67","author":"Z Arlin","year":"1983","unstructured":"Arlin Z (1983) Current status of amsacrine combination chemotherapy programs in acute leukemia. Cancer Treat Rep 67: 967","journal-title":"Cancer Treat Rep"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/jm00276a011","volume":"15","author":"GJ Atwell","year":"1972","unstructured":"Atwell GJ, Cain BF, Seelye RN (1972) Potential antitumor agents: 12.9-Anilinoacridines. J Med Chem 15: 611","journal-title":"J Med Chem"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/jm00387a014","volume":"30","author":"GJ Atwell","year":"1987","unstructured":"Atwell GJ, Rewcastle GW, Baguley BC, Denny WA (1987) Potential antitumor agents: 50. In vivo solid tumor activity of derivatives ofN-[2-(dimethylamino)ethyl]-acridine-4-carboxamide. J Med Chem 30: 664","journal-title":"J Med Chem"},{"key":"CR4","first-page":"3245","volume":"44","author":"BC Baguley","year":"1984","unstructured":"Baguley BC, Denny WA, Atwell GJ, Finlay GJ, Rewcastle GW, Twigden SJ, Wilson WR (1984) Synthesis, antitumor activity and DNA binding properties of a new derivative of amsacrine,N, 5-dimethyl-9-(2-methoxy-4-methylsulfonyl-amino)-4-acridine carboxamide. Cancer Res 44: 3245","journal-title":"Cancer Res"},{"key":"CR5","volume-title":"Amsacrine; current perspectives and clinical results with a new anticancer agent","year":"1983","unstructured":"Bodey GP, Jacquillat C (eds) (1983) Amsacrine; current perspectives and clinical results with a new anticancer agent. Communication Media for Education, Inc., Newark, New Jersey"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0014-2964(74)90079-6","volume":"10","author":"BF Cain","year":"1974","unstructured":"Cain BF, Atwell GJ (1974) The experimental antitumor properties of 3 congeners of the acridinyl methane-sulphonanilide (AMSA) series. Eur J Cancer 10: 539","journal-title":"Eur J Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/jm00255a003","volume":"17","author":"BF Cain","year":"1974","unstructured":"Cain BF, Seelye RN, Atwell GJ (1974) Potential antitumor agents: 14. Acridinyl methanesulphonanilides. J Med Chem 17: 922","journal-title":"J Med Chem"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00005072-198801000-00004","volume":"47","author":"BL Coomber","year":"1988","unstructured":"Coomber BL, Stewart PA, Hayakawa EM, Farrel CL, Del Maestro RF (1988) A quantitative assessment of microvessel ultrastructure in C-6 astrocytoma spheroids transplanted to brain and to muscle. J Neuropathol Exp Neurol 47: 29","journal-title":"J Neuropathol Exp Neurol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1172\/JCI109419","volume":"63","author":"EM Cornford","year":"1979","unstructured":"Cornford EM, Bocash WD, Braun LD, Crane PD, Oldendorf WH (1979) Rapid distribution of tryptophol (3-indolethanol) to the brain and other tissues. J Clin Invest 63: 1241","journal-title":"J Clin Invest"},{"key":"CR10","first-page":"H553","volume":"238","author":"EM Cornford","year":"1980","unstructured":"Cornford EM, Braun LD, Pardridge WM, Oldendorf WH (1980) Blood flow rate and cellular influx of glucose and arginine in mouse liver in vivo. Am J Physiol 238: H553","journal-title":"Am J Physiol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"C161","DOI":"10.1152\/ajpcell.1982.243.3.C161","volume":"243","author":"EM Cornford","year":"1982","unstructured":"Cornford EM, Braun LD, Oldendorf WH, Hill MA (1982) Comparison of lipid mediated blood-brain barrier permeability in the newborn and adult brain. Am J Physiol 243: C161","journal-title":"Am J Physiol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/jcbfm.1983.42","volume":"3","author":"EM Cornford","year":"1983","unstructured":"Cornford EM, Pardridge WM, Braun LD, Oldendorf WH (1983) Increased blood-brain barrier transport of protein bound anticonvulsant drugs in the newborn. J Cerebr Blood Flow Metab 3: 280","journal-title":"J Cerebr Blood Flow Metab"},{"key":"CR13","first-page":"141","volume":"1","author":"WA Denny","year":"1986","unstructured":"Denny WA, Roos IAG, Wakelin PG (1986) Inter-relations between anti-tumor activity, DNA breakage and DNA binding kinetics for 9-aminoacridine-carboxamide antitumor agents. Anticancer Drug Des 1: 141","journal-title":"Anticancer Drug Des"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2307\/2528490","volume":"20","author":"CW Dunnett","year":"1964","unstructured":"Dunnett CW (1964) New tables for multiple comparisons with a control. Biometrics 20: 482","journal-title":"Biometrics"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0277-5379(89)90019-9","volume":"25","author":"GJ Finlay","year":"1989","unstructured":"Finlay GJ, Baguley BC (1989) Selectivity ofN-[2-(dimethylamino)ethyl]-acridine-4-carboxamide towards Lewis lung carcinoma in human tumor cell lines in vitro. Eur J Cancer Clin Oncol 25: 271","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0305-7372(84)90006-9","volume":"11","author":"MH Greig","year":"1984","unstructured":"Greig MH (1984) Chemotherapy of brain metastases: current status. Cancer Treat Rev 11: 157","journal-title":"Cancer Treat Rev"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(87)90048-X","volume":"14","author":"MH Greig","year":"1987","unstructured":"Greig MH (1987) Optimising drug delivery to brain tumors. Cancer Treat Rev 14: 1","journal-title":"Cancer Treat Rev"},{"key":"CR18","first-page":"941","volume-title":"Cancer treatment","author":"CM Haskell","year":"1990","unstructured":"Haskell CM (1990) Investigational chemotherapeutic agents. In: Haskell CM (ed) Cancer treatment, 3rd edn. W. B. Saunders, Philadelphia, p 941","edition":"3rd edn."},{"key":"CR19","first-page":"503","volume":"50","author":"P Kestell","year":"1989","unstructured":"Kestell P, Paxton JW, Evans PC, Young D, Jurlina JL, Robertson IGC, Baguley BC (1989) Disposition of amsacrine and its analogue 9-({2-methoxy-4-[(methyl sulfonyl)-amino]phenyl}amino)-,5-dimethyl-4-acridine carboxamide (CI-921) in plasma, liver and Lewis lung tumors in mice. Cancer Res 50: 503","journal-title":"Cancer Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/jm00180a022","volume":"23","author":"VA Levin","year":"1980","unstructured":"Levin VA (1980) Relationship of octanol\/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23: 682","journal-title":"J Med Chem"},{"key":"CR21","first-page":"28","volume-title":"Fundamentals of cancer chemotherapy","author":"VA Levin","year":"1987","unstructured":"Levin VA (1987) Pharmacokinetics in central nervous system chemotherapy. In: Hellmann K, Carter SK (eds) Fundamentals of cancer chemotherapy. McGraw-Hill, New York, pp 28?47"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4615-7255-8_5","volume-title":"Implications of the blood-brain barrier and its manipulation: clinical aspects, vol 2","author":"EA Neuwelt","year":"1989","unstructured":"Neuwelt EA, Dahlborg SA (1989) Blood-brain barrier disruption in the treatment of brain tumors: clinical implications. In: Neuwelt EA (ed) Implications of the blood-brain barrier and its manipulation: clinical aspects, vol 2. Plenum, New York, pp 195?262"},{"key":"CR23","first-page":"214","volume":"43","author":"E Neuwelt","year":"1983","unstructured":"Neuwelt E, Rapoport S (1983) Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed Proc 43: 214","journal-title":"Fed Proc"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1227\/00006123-198610000-00011","volume":"19","author":"EA Neuwelt","year":"1986","unstructured":"Neuwelt EA, Howieson J, Finkel EP, Specht HD, Weigel R, Buchanan CG, Hill SA (1986) Therapeutic efficacy of multi-agent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma. Neurosurgery 19: 573","journal-title":"Neurosurgery"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0006-8993(70)90123-X","volume":"24","author":"WH Oldendorf","year":"1970","unstructured":"Oldendorf WH (1970) Measurement of brain uptake of radiolabelled substances using tritiated water [as the] internal standard. Brain Res 24: 372","journal-title":"Brain Res"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3181\/00379727-147-38444","volume":"47","author":"WH Oldendorf","year":"1974","unstructured":"Oldendorf WH (1974) Lipid solubility and drug penetration of the blood barrier. Proc Soc Exp Biol Med 47: 813","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0006-8993(76)90024-X","volume":"113","author":"WH Oldendorf","year":"1976","unstructured":"Oldendorf WH, Braun LD (1976) [3H]-Tryptamine and [3H]-water as diffusible internal standards for measuring brain extraction of radiolabeled substances following intracarotid injection. Brain Res 113: 219","journal-title":"Brain Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1152\/ajplegacy.1976.230.1.94","volume":"230","author":"WH Oldendorf","year":"1976","unstructured":"Oldendorf WH, Szabo J (1976) Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am J Physiol 230: 94","journal-title":"Am J Physiol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/jcbfm.1985.86","volume":"5","author":"WM Pardridge","year":"1985","unstructured":"Pardridge WM, Landaw EM, Miller LP, Braun LD, Oldendorf WH (1985) Carotid artery injection technique; bounds for bolus mixing by plasma and by brain. J Cerebr Blood Flow Metab 5: 576","journal-title":"J Cerebr Blood Flow Metab"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00686007","volume":"29","author":"JW Paxton","year":"1992","unstructured":"Paxton JW, Young D, Evans SMH, Kestell P, Robertson IGC, Cornford EM (1992) Pharmacokinetics and toxicity of a new antitumor agent,N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in the mouse. Cancer Chemother Pharmacol 29: 379","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-94-009-3347-7_71","volume-title":"Brain oncology, biology, diagnosis and therapy","author":"DJ Stewart","year":"1987","unstructured":"Stewart DJ (1987) Human central nervous system pharmacology of antineoplastic agents: implications for the treatment of brain tumors. In: Chatel M, Darcel E, Pecker J (eds) Brain oncology, biology, diagnosis and therapy. Martinus Nijhoff, Dordrecht, pp 387?395"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF00254602","volume":"12","author":"DJ Stewart","year":"1984","unstructured":"Stewart DJ, Zhengang G, Lu K, Savarai N, Feun LG, Luna M, Benjamin RS, Keating MJ, Loo TL (1984) Human tissue distribution of 4?-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141 549, AMSA). Cancer Chemother Pharmacol 12: 116","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF00688129","volume":"67","author":"PA Stewart","year":"1985","unstructured":"Stewart PA, Hayakawa K, Hayakawa E, Farrel CL, Del Maestro R (1985) A quantitative study of blood-brain barrier permeability ultrastructure in a new rat glioma model. Acta Neuropathol (Berlin) 67: 96","journal-title":"Acta Neuropathol (Berlin)"},{"key":"CR34","first-page":"H484","volume":"247","author":"Y Takasato","year":"1984","unstructured":"Takasato Y, Rapoport SI, Smith QR (1984) An in situ brain perfusion technique to study cerebral vascular transport in the rat. Am J Physiol 247: H484","journal-title":"Am J Physiol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1210\/endo-121-3-1185","volume":"121","author":"T Terasaki","year":"1987","unstructured":"Terasaki T, Pardridge WM (1987) Stereospecificity of triiodothyronine transport into brain, liver and salivary gland. Role of carrier-and plasma protein-mediated transport. Endocrinology 121: 1185","journal-title":"Endocrinology"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01059283","volume":"14","author":"SC Tsao","year":"1980","unstructured":"Tsao SC, Sugiyama Y, Sawada Y, Nagase S, Iga T, Hanano W (1980) Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic rats: analysis by multiple indicator dilution method. Pharmacokinet Biopharm 14: 51","journal-title":"Pharmacokinet Biopharm"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00179589","volume":"4","author":"C Unger","year":"1986","unstructured":"Unger C, Eibl H, Heyden HW von, Kim DJ, Nagel GA (1986) Aminogluthethimide penetration of the blood brain barrier. Invest New Drugs 4: 237","journal-title":"Invest New Drugs"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/07357908309020272","volume":"1","author":"G Zhengang","year":"1983","unstructured":"Zhengang G, Savaraj N, Feun LG, Lu K, Stewart DJ, Luna M, Benjamin RS, Loo TL (1983) Tumor penetration of AMSA in man. Cancer Invest 1: 475","journal-title":"Cancer Invest"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00684844.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00684844\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00684844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T11:13:48Z","timestamp":1585998828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00684844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1992]]}},"alternative-id":["BF00684844"],"URL":"https:\/\/doi.org\/10.1007\/bf00684844","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992]]}}}